Salarius Pharmaceuticals Financial Overview
Salarius Pharmaceuticals's market cap is currently $3.91M. The company's EPS TTM is $-6.768; its P/E ratio is -0.02; Salarius Pharmaceuticals is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
